Status:
UNKNOWN
Steroid Injection for Adhesive Capsulitis
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Adhesive Capsulitis
Eligibility:
All Genders
35-70 years
Phase:
NA
Brief Summary
This study was conducted to compare the efficacy of hydrodilatation with low dose steroid with high dose steroid for treating adhesive capsulitis.
Detailed Description
Design: a prospective, double-blinded, randomized, clinical trial Patient and methods: Patients with adhesive capsulitis for at least 3 months were enrolled and randomly allocated into group 1 (hydr...
Eligibility Criteria
Inclusion
- clinical diagnosis of adhesive capsulitis
- a duration of complaints more than 3 months
- a reduction in passive range of motion in at least 2 of the following: forward flexion, abduction, or external rotation of the affected shoulder of more than 30 degree compared with the other side.
Exclusion
- prior manipulation of the affected shoulder under anesthesia;
- other conditions involving the shoulder ( rheumatoid arthritis, Hill-Sachs lesions, osteoarthritis, damage to the glenohumeral cartilage,osteoporosis, or malignancies in the shoulder region);
- neurologic deficits affecting shoulder function in normal daily activities;
- shoulder pain caused by cervical radiculopathy
- a history of drug allergy to hyaluronic acid;
- pregnancy or lactation;
- received injection into the affected shoulder during the preceding 3 months
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04364425
Start Date
May 4 2020
End Date
September 1 2021
Last Update
May 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei veteran general hospital
Taipei, Taiwan